Solis, Banzanita .

HRN: 24-75-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
CEFUROXIME 750MG (VIAL)
03/14/2024
03/20/2024
IV
750mg
Q8
UTI

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines